Some of Arnold & Porter's most impressive work stems from its strong reputation among major life sciences sector companies, which instruct the firm on mergers, on abuse of dominance complaints and on broader advisory matters relating to the roll-out of new drugs or vaccines. The firm has also acted on phase II EU merger investigations of planned IT sector transactions, working together with lawyers in Washington, DC to coordinate US antitrust filings.
Luc Gyselen is an experienced competition lawyer with a broad practice. He is recognised among market commentators as an important figure with experience in state aid and competition matters, including representing clients in cartel investigations.
Clients say that Niels Ersbøll is "extremely pragmatic, which is really important and means that he is good at speaking to our internal commercial teams." "He knows all the details of what's going on in all of our matters," states another source, adding: "Even when I know he's got other matters on, I always feel like I am top of the list." Niels Ersbøll assists pharmaceutical companies with mergers and with competition law questions concerning the distribution of new products, including vaccines.
Axel Gutermuth has experience in high-value, complex merger control mandates in the technology and life sciences sectors. Clients report that he is "thoughtful, informed and attentive." Another source states that "he has the respect of the EC, which brings a level of credibility because he's able to communicate with the EC on our behalf." Axel Gutermuth is German law-qualified and assists with merger filings to the Bundeskartellamt.